Bliss GVS Pharma: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results

Bliss GVS Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, January 01, 2026, and will continue unti...

Bliss GVS Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, January 01, 2026, and will continue until 48 hours after the announcement of the unaudited financial results for the quarter and nine months ended December 31, 2025. The company has informed the Listing Departments of the National Stock Exchange of India and BSE Limited about this closure, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. Insiders, designated persons, and their immediate relatives are advised against trading in the company's shares during this period. The date of the Board Meeting to consider the financial results will be intimated later.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Bliss GVS Pharma Limited in the news today?

Bliss GVS Pharma Limited (BLISSGVS) is in the news due to the announcement is a standard regulatory disclosure regarding the closure of the trading window, which is a routine procedure and does not inherently indicate positive or negative performance or outlook for the company.

Trading Window DisclosureInsider Trading
Bliss GVS Pharma LimitedBLISSGVShttps://prysm.fi/v2/analyze/BLISSGVS

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Bliss GVS Pharma: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results

December 30, 2025, 07:15 AM

AI Sentiment Analysis

Top Queries to Ask About Bliss GVS Pharma Limited

More Details on This News

Bliss GVS Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, January 01, 2026, and will continue until 48 hours after the announcement of the unaudited financial results for the quarter and nine months ended December 31, 2025. The company has informed the Listing Departments of the National Stock Exchange of India and BSE Limited about this closure, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. Insiders, designated persons, and their immediate relatives are advised against trading in the company's shares during this period. The date of the Board Meeting to consider the financial results will be intimated later.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Bliss GVS Pharma Limited

Discover more trending news on Prysm

View All